Sanofi's COVID vaccine trial ends early – what we know

NCT ID NCT04904549

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This Phase 3 study tested two Sanofi COVID-19 vaccines (one targeting the original virus, another targeting two variants) in about 24,000 adults. The goal was to see if they could prevent COVID-19 safely. The trial was terminated early, so final results are limited, but the data may still help improve future vaccines.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent and bivalent)

What this could lead to

If successful, this could provide a new option for COVID-19 vaccination, potentially offering protection against multiple variants.

What could go wrong

The trial was terminated early, so data may be incomplete. As a Phase 3 study, it was large but results may not apply to newer variants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AES - DRS - Simon Williamson Clinic, PC - Birmingham- Site Number : 8400004

    Birmingham, Alabama, 35211, United States

  • AES Austin- Site Number : 8400003

    Austin, Texas, 78744, United States

  • AES Salt Lake City- Site Number : 8400016

    Murray, Utah, 84123, United States

  • AES St. Petersburg- Site Number : 8400017

    Pinellas Park, Florida, 33781, United States

  • American Indian Clinical Trials Research Network Site Number : 8400025

    Rapid City, South Dakota, 57701, United States

  • Coastal Carolina Research Center - N Charleston- Site Number : 8400022

    North Charleston, South Carolina, 29405, United States

  • Investigational Site Number : 1700001

    Bogotá, 111611, Colombia

  • Investigational Site Number : 1700002

    Barranquilla, 080020, Colombia

  • Investigational Site Number : 1700003

    Soledad, 083001, Colombia

  • Investigational Site Number : 1700004

    Floridablanca, 681004, Colombia

  • Investigational Site Number : 1700005

    Cali, 76001, Colombia

  • Investigational Site Number : 1700006

    Chía, 0000, Colombia

  • Investigational Site Number : 1700007

    Girardot, 252431, Colombia

  • Investigational Site Number : 1700008

    Barranquilla, 080020, Colombia

  • Investigational Site Number : 1700009

    Meta, 0000, Colombia

  • Investigational Site Number : 1700010

    Aguazul, 856018, Colombia

  • Investigational Site Number : 1700015

    Quindío, 630001, Colombia

  • Investigational Site Number : 2880001

    Navrongo, 114, Ghana

  • Investigational Site Number : 2880002

    Kintampo, P. O. Box 200, Ghana

  • Investigational Site Number : 2880003

    Kumasi, 00000, Ghana

  • Investigational Site Number : 3400001

    Municipio Del Distrito Central, 11101, Honduras

  • Investigational Site Number : 3400002

    San Pedro Sula, 21104, Honduras

  • Investigational Site Number : 3560001

    Jaipur, 302039, India

  • Investigational Site Number : 3560002

    Ambawadi, 380015, India

  • Investigational Site Number : 3560003

    Punjagutta, 500082, India

  • Investigational Site Number : 3560004

    Patna, 801507, India

  • Investigational Site Number : 3560005

    Kanpur, 208002, India

  • Investigational Site Number : 3560006

    Tamilnadu, 603203, India

  • Investigational Site Number : 3560007

    Belagavi, 590002, India

  • Investigational Site Number : 3560009

    Nagpur, 440001, India

  • Investigational Site Number : 3560010

    Ajmer, 305001, India

  • Investigational Site Number : 3560011

    Odisha, 751003, India

  • Investigational Site Number : 3920001

    Kyobashi Chuo-ku, Tokyo, 104-0031, Japan

  • Investigational Site Number : 3920002

    Ohta-ku, Tokyo, 143-0015, Japan

  • Investigational Site Number : 3920003

    Kouenji minami,Suginami-ku, Tokyo, 166-0003, Japan

  • Investigational Site Number : 3920004

    Haramachi,Shinjuku-ku, Tokyo, 162-0053, Japan

  • Investigational Site Number : 3920005

    Chiyoda-ku,, Tokyo, 101-0041, Japan

  • Investigational Site Number : 4040001

    Nairobi, 00100GPO, Kenya

  • Investigational Site Number : 4040002

    Kisumu, 40100, Kenya

  • Investigational Site Number : 4040003

    Kisumu, 40100, Kenya

  • Investigational Site Number : 4040004

    Kericho, 00200, Kenya

  • Investigational Site Number : 4040006

    Eldoret, 30100, Kenya

  • Investigational Site Number : 4040007

    Nairobi, 00100, Kenya

  • Investigational Site Number : 4040008

    Mombasa, 80107 Ganjoni, Kenya

  • Investigational Site Number : 4040009

    Thika, 00202 Kiambu, Kenya

  • Investigational Site Number : 4040011

    Butere, 50101, Kenya

  • Investigational Site Number : 4040012

    Kisumu, 40123 Kisumu, Kenya

  • Investigational Site Number : 4840002

    Veracruz, 91910, Mexico

  • Investigational Site Number : 4840003

    Guadalajara, Jalisco, 44280, Mexico

  • Investigational Site Number : 4840004

    Acapulco de Juárez, Guerrero, 39670, Mexico

  • Investigational Site Number : 4840005

    León, Guanajuato, 37000, Mexico

  • Investigational Site Number : 4840006

    Temixco, 62587, Mexico

  • Investigational Site Number : 4840008

    Cuernavaca, Morelos, 62290, Mexico

  • Investigational Site Number : 4840009

    Mexico City, Mexico City, 04530, Mexico

  • Investigational Site Number : 5240001

    Nepalgunj, 21900, Nepal

  • Investigational Site Number : 5240002

    Dhulikhel, 45200, Nepal

  • Investigational Site Number : 5240003

    Kathmandu, 44600, Nepal

  • Investigational Site Number : 8000001

    Kampala, 0, Uganda

  • Investigational Site Number : 8000002

    Entebbe, 0, Uganda

  • Investigational Site Number : 8000003

    Kampala, 42 Nakasero Road, Uganda

  • Investigational Site Number : 8000004

    Kampala, Plot 101, Lubowa, Uganda

  • Investigational Site Number : 8000005

    Entebbe, 0, Uganda

  • Investigational Site Number : 8000007

    Kampala, 23491, Uganda

  • Investigational Site Number : 8000013

    Kampala, 10101, Uganda

  • Investigational Site Number : 8000014

    Lira, 10101, Uganda

  • Investigational Site Number : 8040001

    Kyiv, 03037, Ukraine

  • Investigational Site Number : 8040002

    Kiev, 04210, Ukraine

  • Investigational Site Number : 8040003

    Kyiv, 02002, Ukraine

  • Investigational Site Number : 8040004

    Kyiv, 01023, Ukraine

  • Optimal Research Alabama- Site Number : 8400019

    Huntsville, Alabama, 35802, United States

  • Optimal Research, LLC-Melbourne- Site Number : 8400002

    Melbourne, Florida, 32934, United States

  • Peninsula Research Associates, Inc.- Site Number : 8400021

    Rolling Hills Estates, California, 90274, United States

  • Rochester Clinical Research, Inc.- Site Number : 8400023

    Rochester, New York, 14609, United States

  • Synexus Akron- Site Number : 8400009

    Akron, Ohio, 44311, United States

  • Synexus Clinical Research Anderson- Site Number : 8400007

    Anderson, South Carolina, 29621, United States

  • Synexus Clinical Research Chicago- Site Number : 8400012

    Chicago, Illinois, 60602, United States

  • Synexus Clinical Research Evansville- Site Number : 8400008

    Evansville, Indiana, 47714, United States

  • Synexus Clinical Research US, Inc. - Atlanta- Site Number : 8400005

    Atlanta, Georgia, 30328, United States

  • Synexus Clinical Research US, Inc. - Cincinnati- Site Number : 8400010

    Cincinnati, Ohio, 45236, United States

  • Synexus Clinical Research US, Inc. - Henderson- Site Number : 8400018

    Henderson, Nevada, 89052, United States

  • Synexus Clinical Research US, Inc. - Orlando- Site Number : 8400020

    Orlando, Florida, 32806, United States

  • Synexus Clinical Research US, Inc. - San Antonio- Site Number : 8400015

    San Antonio, Texas, 78229, United States

  • Synexus Clinical Research US, Inc. Site Number : 8400013

    Centennial, Colorado, 80112, United States

  • Synexus Dallas- Site Number : 8400014

    Dallas, Texas, 75231, United States

  • Synexus St. Louis- Site Number : 8400006

    St Louis, Missouri, 63141, United States

  • Synexus US Columbus- Site Number : 8400011

    Columbus, Ohio, 43212, United States